Discussion To the best of our knowledge, the incidence of cancer attributable to SB has not been previously investigated for Germany. Our study revealed that in 2024, more than 10% of cancer cases in Germany will be attributable to SB, which underscores the significant contribution of SB to the growing cancer burden in the country.